Literature DB >> 32469456

Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Nontremor Items.

Michelle Hyczy de Siqueira Tosin1,2, Christopher G Goetz2, Sheng Luo3, Dongrak Choi3, Glenn T Stebbins2.   

Abstract

BACKGROUND: In PD, tremor severity behaves differently from other core motor features. However, the most commonly used assessment of overall motor severity, total MDS-UPDRS Motor Examination (Part 3) score, does not account for this distinction.
OBJECTIVES: To investigate the Motor Examination (Part 3) using Item Response Theory approaches focusing on sample-independent strategies that assess how well items measure latent models of PD motor severity.
METHODS: Data from 6,298 PD patients were analyzed with graded response model Item Response Theory approaches involving two analyses all 33 Part 3 items versus the 10 tremor items and 23 bradykinesia, rigidity, gait, and posture items considered separately. The strength of relationship between items and the latent measure of parkinsonian motor severity (discrimination parameter) and calculated thresholds (location parameters) were assessed using the mirt program implemented in R (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS: Analyzing all Part 3 items together, nontremor items demonstrated good discrimination parameters (mean = 1.83 ± 0.37) and range of thresholds (-1.73 to +4.42), but tremor items had poor discrimination (mean = 0.52 ± 0.76) and thresholds (-0.69 to 14.29). Segregating nontremor from tremor items in two independent analyses provided markedly improved discrimination and location parameters for both.
CONCLUSIONS: MDS-UPDRS Part 3 tremor and nontremor items have very different relations to the construct of PD severity. Strongly improved clinimetric properties for Part 3 are obtained when tremor and nontremor items are considered separately. We suggest that evaluating PD motor severity, as an operationalized summary measure, is best attained through separate analyses with tremor and nontremor motor scores.
© 2020 International Parkinson and Movement Disorder Society. © 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  MDS-UPDRS; Parkinson's disease; clinimetrics; item response theory

Mesh:

Year:  2020        PMID: 32469456     DOI: 10.1002/mds.28110

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

1.  Application of longitudinal item response theory models to modeling Parkinson's disease progression.

Authors:  Haotian Zou; Varun Aggarwal; Glenn T Stebbins; Martijn L T M Müller; Jesse M Cedarbaum; Anne Pedata; Diane Stephenson; Tanya Simuni; Sheng Luo
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-08-09

2.  Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine.

Authors:  Sheng Luo; Christopher G Goetz; Dongrak Choi; Sanket Aggarwal; Tiago A Mestre; Glenn T Stebbins
Journal:  Mov Disord       Date:  2022-06-18       Impact factor: 9.698

3.  Does MDS-UPDRS Provide Greater Sensitivity to Mild Disease than UPDRS in De Novo Parkinson's Disease?

Authors:  Michelle H S Tosin; Glenn T Stebbins; Cynthia Comella; Charity G Patterson; Deborah A Hall
Journal:  Mov Disord Clin Pract       Date:  2021-09-06

4.  Will Artificial Intelligence Outperform the Clinical Neurologist in the Near Future? No.

Authors:  Christopher G Goetz
Journal:  Mov Disord Clin Pract       Date:  2021-04-12

5.  Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models.

Authors:  Sheng Luo; Haotian Zou; Christopher G Goetz; Dongrak Choi; David Oakes; Tanya Simuni; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2021-08-03

6.  Tracking Emergence of New Motor and Non-Motor Symptoms Using the MDS-UPDRS: A Novel Outcome Measure for Early Parkinson's Disease?

Authors:  Michelle H S Tosin; Tanya Simuni; Glenn T Stebbins; Jesse M Cedarbaum
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.